UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field

Cancers, 2023-08, Vol.15 (16), p.4125

2023

Volltextzugriff (PDF)

The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review

Clinical and Applied Thrombosis/Hemostasis, 2021-01, Vol.27, p.10760296211012093-10760296211012093

2021

Volltextzugriff (PDF)

A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab

International journal of molecular sciences, 2023-05, Vol.24 (9), p.8167

2023

Volltextzugriff (PDF)

Genetic Polymorphism Effect on Warfarin-Rifampin Interaction: A Case Report and Review of Literature

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.149-156

2021

Volltextzugriff (PDF)

The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors

Cancers, 2023-10, Vol.15 (20), p.4913

2023

Volltextzugriff (PDF)

Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey

Journal of thrombosis and thrombolysis, 2020-11, Vol.50 (4), p.957-968

2020

Volltextzugriff (PDF)

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review

Cancers, 2023-04, Vol.15 (9), p.2561

2023

Volltextzugriff (PDF)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.1069-1080

2021

Volltextzugriff (PDF)

185 Global and local copy number aberration signatures as prognostic and immunotherapeutic predictors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A209-A209

2023

Volltextzugriff (PDF)

D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review

Vascular health and risk management, 2020-01, Vol.16, p.455-462

2020

Volltextzugriff (PDF)

A bibliometric analysis and typology of drug pricing policies across the globe

Medicine (Baltimore), 2024-10, Vol.103 (42), p.e40112

2024

Volltextzugriff (PDF)

Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management

Current problems in cardiology, 2023-06, Vol.48 (6), p.101128-101128, Article 101128

2023

Volltextzugriff (PDF)

Treatment of Stage III Resectable Melanoma-Adjuvant and Neoadjuvant Approaches

The cancer journal (Sudbury, Mass.), 2024-03, Vol.30 (2), p.54-70

2024

Volltextzugriff (PDF)

Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema

Value in health regional issues, 2020-09, Vol.22, p.23-26

2020

Volltextzugriff (PDF)

Assessing the Performance of In silico Tools and Molecular Dynamics Simulations for Predicting Pharmacogenetic Variant Impact

Clinical pharmacology and therapeutics, 2024-10, Vol.116 (4), p.1082-1089

2024

Volltextzugriff (PDF)

High dose bolus (HDB) interleukin-2 (IL2) and concurrent low dose ipilimumab followed sequentially by nivolumab in patients with advanced melanoma after failure of anti-PD1-based immunotherapy and BRAF-MEK inhibition

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.9543-9543

2024

Volltextzugriff (PDF)

Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma

Clinical cancer research, 2024-11, p.OF1-OF9

2024

Volltextzugriff (PDF)

A prognostic model based on selected cell state and cellular community scores in patients with advanced melanoma treated with immune checkpoint inhibitors (Ecotype-ICI score) as a predictor of ICI immunotherapeutic benefits

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.9568-9568

2024

Volltextzugriff (PDF)

Racial/Ethnic Disparities in Use of Angiotensin II Receptor Type 2/4 Stimulatory Vs. Inhibitory Antihypertensive Among Hypertensive Adults in the USA

Journal of racial and ethnic health disparities, 2024-03

2024

Volltextzugriff (PDF)

Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries

Expert review of pharmacoeconomics & outcomes research, 2018-07, Vol.18 (4), p.403-414

2018

Volltextzugriff (PDF)

Bridging vs Non-Bridging with Warfarin Peri-Procedural Management: Cost and Cost-Effectiveness Analyses

Current problems in cardiology, 2021-11, Vol.46 (11), p.100839-100839, Article 100839

2021

Volltextzugriff (PDF)

Corrigendum to “Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study”. [Current Problems in Cardiology Volume 46, Issue 6, June 2021, 100816]

Current problems in cardiology, 2021-12, Vol.46 (12), p.100899-100899, Article 100899

2021

Volltextzugriff (PDF)

Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study

Current problems in cardiology, 2021-06, Vol.46 (6), p.100816-100816, Article 100816

2021

Volltextzugriff (PDF)

Abstract 71: Differential infiltration of key immune cell populations across malignancies varying by immunogenic potential and likelihood of response to immunotherapy

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.71-71

2024

Volltextzugriff (PDF)

The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors

Cancer research communications, 2024-08, Vol.4 (8), p.1978-1990

2024

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(27)
Berichte
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field

The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review

A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab

Genetic Polymorphism Effect on Warfarin-Rifampin Interaction: A Case Report and Review of Literature

The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors

Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management

185 Global and local copy number aberration signatures as prognostic and immunotherapeutic predictors

D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review

A bibliometric analysis and typology of drug pricing policies across the globe

Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management

Treatment of Stage III Resectable Melanoma-Adjuvant and Neoadjuvant Approaches

Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema

Assessing the Performance of In silico Tools and Molecular Dynamics Simulations for Predicting Pharmacogenetic Variant Impact

High dose bolus (HDB) interleukin-2 (IL2) and concurrent low dose ipilimumab followed sequentially by nivolumab in patients with advanced melanoma after failure of anti-PD1-based immunotherapy and BRAF-MEK inhibition

Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma

A prognostic model based on selected cell state and cellular community scores in patients with advanced melanoma treated with immune checkpoint inhibitors (Ecotype-ICI score) as a predictor of ICI immunotherapeutic benefits

Racial/Ethnic Disparities in Use of Angiotensin II Receptor Type 2/4 Stimulatory Vs. Inhibitory Antihypertensive Among Hypertensive Adults in the USA

Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries

Bridging vs Non-Bridging with Warfarin Peri-Procedural Management: Cost and Cost-Effectiveness Analyses

Corrigendum to “Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study”. [Current Problems in Cardiology Volume 46, Issue 6, June 2021, 100816]

Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study

Abstract 71: Differential infiltration of key immune cell populations across malignancies varying by immunogenic potential and likelihood of response to immunotherapy

The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors

Suchergebnisse filtern